Correvio Pharma Corp. Income Tax Expense
Correvio Pharma Corp. reported Income Tax Expense of $179.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2020-04-30
| Period end | Income Tax Expense (Benefit) 12 month |
|---|---|
| 2019-12-31 | $179.00K 20-F · filed 2020-04-30 |
| 2018-12-31 | $38.00K 20-F · filed 2020-04-30 |
| 2017-12-31 | $363.00K 20-F · filed 2020-04-30 |
| 2016-12-31 | $152.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | -$11.00K 20-F · filed 2018-04-30 |
| 2014-12-31 | $49.00K 40-F · filed 2016-03-29 |
| 2013-12-31 | $102.00K 40-F · filed 2015-03-27 |
| 2012-12-31 | $0.00 40-F/A · filed 2014-04-30 |